Device Trial Radar · NCT04712526
Endostapler Gastric Bypass Study
Last checked: Nov 20, 2026Latest source record: Oct 4, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Jan 18, 2021
Primary completion
Nov 2023
Study completion Dec 2023
Sponsor
- Lead sponsor
- Lexington Medical Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 15, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this prospective, post-market study is to evaluate safety and efficacy of the AEON™ Endostapler when used in laparoscopic Roux-en-Y gastric bypass surgery.
Conditions
- Obesity
Interventions
AEON EndostaplerDevice
Surgery with AEON Endostapler
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of reported device-related adverse eventsTime frame: Within 30-day post-operative period
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Holyoke Medical Center
Holyoke, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.